Heparin is not required for peripheral intravenous locks in neonates

Area of Science:

• Neonatal care
• Pediatric pharmacology
• Vascular access devices

Background:

• Peripheral intravenous (IV) locks are crucial for medication administration in neonates.
• Maintaining patency of IV locks is essential to prevent complications and ensure effective treatment.
• Heparinized saline is sometimes used to maintain IV lock patency, but its necessity and safety in neonates require evaluation.

Purpose of the Study:

• To compare the efficacy and safety of heparinized saline versus normal saline for maintaining peripheral IV locks in neonates.
• To assess differences in catheter lifespan, occlusion rates, and complications between the two maintenance solutions.

Main Methods:

• A randomized controlled trial was conducted in a neonatal intensive care unit (NICU).
• Neonates requiring IV locks were randomized to receive either heparinized saline (5 units/mL) or normal saline (0.3 mL) every 6 hours.
• Blinded administration by nursing staff ensured unbiased data collection.

Main Results:

• No significant differences were observed in catheter lifespan or the number of IV catheters per patient between the heparinized and normal saline groups.
• Reasons for catheter removal, skin site complications, and systemic bleeding (including intracranial hemorrhage) did not differ between groups.
• Catheter occlusion risk was inversely correlated with gestational age and specific antibiotic regimens (vancomycin/cefotaxime vs. ampicillin/gentamicin).

Conclusions:

• Heparin is not required for maintaining peripheral IV locks in neonates, irrespective of the saline solution used.
• Catheter occlusion in neonates is more strongly associated with lower gestational age and the administration of certain antibiotic combinations.